Skip to content

A clinical study for blood pressure variability and related risks in treating cerebral small vessel disease with Bushen Huayu integrative medicine

A clinical study for blood pressure variability and related risks in treating cerebral small vessel disease with Bushen Huayu integrative medicine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018873
Enrollment
Unknown
Registered
2018-10-14
Start date
2018-10-31
Completion date
Unknown
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral small vessel disease

Interventions

treatment group:western treatment and tonifying kidney and removing blood stasis chinese medicine
control group:western treatment

Sponsors

Shanghai 6th People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. clinical manifestations: asymptomatic lacunar infarction, CMB and partial leukoaraiosis, various lacunar syndrome and vascular cognitive dysfunction; imaging findings: lacunar infarction (LI) or lacunar (lacune) Or white matter lesions (WML) or perivascular space enlargement or cerebral microbleeds (CMB); 2. no major cerebral vascular disease or intracranial tumor by skull MRI; 3. aged from 40 to 80 years old; 4. MoCA scale < 26 points; 5. subjects volunteered to participate in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. There are other cerebral small vessel diseases such as amyloid angiopathy; other hereditary disease-related small vessel diseases (such as CADSIL, FABRY disease, etc.), inflammation and immune-mediated VCSV and vasculitis, other small venous collagen diseases History of vascular disease; severe arrhythmia such as atrial fibrillation, stroke caused by Parkinson's disease, macrovascular disease, cardiogenic stroke, exclude other diseases that affect intelligence; 2. severe liver and kidney dysfunction; 3. allergic constitution Or those who are allergic to multiple drugs; 4. those with other serious diseases, such as malignant tumors, severe malnutrition, mental disorders, etc.; 5. MoCA scale=26; 6. excluded from macroangiopathy.

Design outcomes

Primary

MeasureTime frame
blood pressure and blood pressure variability;MoCA;PWV/ABI;

Secondary

MeasureTime frame
TC;TG;LDL-c;HDL-c;FPG;2hPG;HbA1c;D-Dimer;

Countries

China

Contacts

Public ContactWang Tian-zhan

Shanghai 6th People's Hospital

jason_tiger@163.com+86 13482540171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026